Aarkstore - Obsessive-Compulsive Disorder-API Insights, 2014

1
Category Pharmaceuticals and Healthcare Market
Research Reports
Aarkstore - Obsessive-Compulsive Disorder-API
Insights, 2014

• Browse Complete Report
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/87933/obsessive-compulsive-disorder-api-insights
  -2014

2
Summary
The active pharmaceutical ingredients worldwide
market is in continuous development from the
recent years. There is expected to be a major
impact on the global API industry, with the large
number of blockbuster drugs going off patent in
the coming years. It is going to affect the
revenue of the API market as generic drugs occupy
the market. India and China produce a large
percentage of a majority of the APIs and
intermediates produced in the world currently.
The USFDA and EMA have strict guidelines for API
manufacturing 'Process Validation General
Principles and Practices'. While countries such
as Japan and Singapore are signatories to the ICH
Q7 regulation, India and China follow their
national GMP guidelines. The efficiency and
expertise of Asian contract manufacturers have
positioned them in a very strategic space in the
global pharmaceutical supply chain, with a vast
majority of the APIs and intermediates being
sourced from markets such as India and
China. DelveInsights, Obsessive-Compulsive
Disorder -API Insights, 2014 Report describes the
current therapeutics that are propelling the
pharmaceutical markets worldwide.
3
Scope of The Report
A snapshot of the global Market therapeutics
scenario for Obsessive-Compulsive Disorder. A
review of the marketed products under
prescription for Obsessive-Compulsive Disorder,
regulatory information and marketing status.
Coverage of global patent coverage and detailed
commentaries on the US patent challenges.
Graphical representation of investigational
products for patent expiry and market
exclusivities across the globe. Product
profiles for marketed products for
Obsessive-Compulsive Disorder with complete
description of mechanism of action, therapeutic
class, target, route(s) of administration and
chemical details. Coverage of API
Manufacturers for Obsessive-Compulsive Disorder
drugs in the United States, Europe and Asian
Regions with location details.
4
Table Of Content

Indication Overview Marketed Drugs
Assessment Marketed Details of Drugs by
Application Type Marketed Details of Drugs (NDA)
by Marketing Status Marketed Details of Drugs by
Patent Expiration Timeline The Active
Pharmaceutical Ingredient (API) Manufacturers
Assessment The API Manufacturers by the United
States Drug Master File (US DMF) Status The API
Manufacturers by the US DMF Status (Drug
Specific) Drugs Market Data and Forecasted Sales
Figures (2011-2015) Marketed Drugs
Information Drugs Description
Global Active Pharmaceutical Manufacturers Approva
l Status Patent and Exclusivity Details Company
Overview Discontinued Drugs Information List Of
Tables Obsessive-Compulsive Disorder Therapeutic
Market, US, Marketed Drugs by Application Type,
2014 Obsessive-Compulsive Disorder Therapeutic
Market, US, Marketed Drugs by Marketing Status,
2014 Obsessive-Compulsive Disorder Therapeutic
Market, US, (Year), 2014
5

Obsessive-Compulsive Disorder Marketed Drugs, API
Manufacturers by US DMF Status,
2014 Obsessive-Compulsive Disorder Marketed
Drugs, US DMF Status Drug Specific (Number),
2014 Obsessive-Compulsive Disorder Therapeutic
Market, Global Sales (in million USD),
2014 Obsessive-Compulsive Disorder Marketed
Drugs, API Manufacturers, Global,
2014 Discontinued Drugs for Obsessive-Compulsive
Disorder, 2014 List Of Figures Obsessive-Compulsi
ve Disorder Therapeutic Market, US, Marketed
Drugs by Application Type (), 2014
Obsessive-Compulsive Disorder Therapeutic Market,
US, Marketed Drugs by Marketing Status (),
2014 Obsessive-Compulsive Disorder Therapeutic
Market, US, (Year), 2014 Obsessive-Compulsive
Disorder Marketed Drugs, API Manufacturers by US
DMF Status (), 2014 Obsessive-Compulsive
Disorder Marketed Drugs, US DMF Status Drug
Specific (Number), 2014 Obsessive-Compulsive
Disorder Therapeutic Market, Global Sales (in
million USD), 2014 Obsessive-Compulsive Disorder
Marketed Drugs, Patent/Exclusivity Expiry (Year),
2014
6
Related Reports

•  MediGene AG (MDG) - Financial and Strategic SWOT
  Analysis Review
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review
• Regis Healthcare Ltd Company Profile and SWOT
  Analysis

7

• Raynauds Disease - Pipeline Review, H2 2014
• High-Grade Glioma - Pipeline Review, H2 2014
• Global Regenerative Medicine Market 2015-2019
• Pharmaceuticals and Healthcare Market Research
  Reports

8
Obsessive-Compulsive Disorder-API Insights,
2014 Published Nov 2014 60 Pages The active
pharmaceutical ingredients worldwide market is in
continuous development from the recent years.
There is expected to be a major impact on the
global API industry, with the large number of
blockbuster drugs going off patent in the coming
years.
9
Contact Us
You Can Visit http//www.aarkstore.com OR Mail
us at contact_at_aarkstore.com Blog
http//www.aarkstore.com/blog/ Conference
http//conference.aarkstore.com/ News
http//www.aarkstore.com/news
Office Aarkstore Enterprise Office No. 809, 8th
Floor, B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15, CBD-Belapur, Navi Mumbai 400614,
Maharashtra, India Phone [phone]
Online Support 91 814 985 2585 Partners
contact 91 808 085 2585